Seven novel mutations and four exon deletions in a collection of Norwegian patients with SPG4 hereditary spastic paraplegia.

Hereditary spastic paraplegia SPG4: what is known and not known about the disease. Brain (2015) 1.28

The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles. Am J Hum Genet (2014) 1.14

Alu-specific microhomology-mediated deletion of the final exon of SPAST in three unrelated subjects with hereditary spastic paraplegia. Genet Med (2011) 1.08

Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia. BMC Neurol (2010) 0.87

Mutation analysis of SPAST, ATL1, and REEP1 in Korean Patients with Hereditary Spastic Paraplegia. J Clin Neurol (2014) 0.83

Partial SPAST and DPY30 deletions in a Japanese spastic paraplegia type 4 family. Neurogenetics (2010) 0.79

Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements. BMC Neurol (2010) 0.76

Novel SPAST deletion and reduced DPY30 expression in a Spastic Paraplegia type 4 kindred. BMC Med Genet (2014) 0.75

SPAST mutation spectrum and familial occurrence among Czech patients with pure hereditary spastic paraplegia. J Hum Genet (2016) 0.75

A polymorphic Alu insertion that mediates distinct disease-associated deletions. Eur J Hum Genet (2016) 0.75

Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia. PLoS One (2017) 0.75

The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit. J Biol Chem (1981) 3.13

Isolation and characterization of Shigella shigae cytotoxin. J Biol Chem (1980) 2.78

Subunit structure of Shigella cytotoxin. J Biol Chem (1981) 2.59

Another case of imprinting defect in a girl with Angelman syndrome who was conceived by intracytoplasmic semen injection. Am J Hum Genet (2003) 1.86

Interaction of Shigella shigae cytotoxin with receptors on sensitive and insensitive cells. J Recept Res (1980) 1.76

Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp Cell Res (1980) 1.69

Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin. J Immunol (1983) 1.60

Polygenic risk score and the psychosis continuum model. Acta Psychiatr Scand (2014) 1.55

Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Neurology (2006) 1.20

Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am J Hum Genet (2000) 1.09

Entry of Shigella dysenteriae toxin into HeLa cells. Infect Immun (1983) 1.06

TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders. Transl Psychiatry (2012) 0.97

EFNS guidelines on the molecular diagnosis of mitochondrial disorders. Eur J Neurol (2009) 0.97

CT characterization of developmental variations of the paranasal sinuses in cystic fibrosis. Acta Radiol (2001) 0.95

Properties and action mechanism of the toxic lectin modeccin: interaction with cell lines resistant to modeccin, abrin, and ricin. J Supramol Struct (1978) 0.92

EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias. Eur J Neurol (2009) 0.91

Phenotype of adult Refsum disease due to a defect in peroxin 7. Neurology (2007) 0.91

Non-random X chromosome inactivation in an affected twin in a monozygotic twin pair discordant for Wiedemann-Beckwith syndrome. Am J Med Genet (1995) 0.90

Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet (1978) 0.90

Carnitine uptake into human heart cells in culture. Biochim Biophys Acta (1977) 0.89

Specificity and characteristics of the carnitine transport in human heart cells (CCL 27) in culture. Biochim Biophys Acta (1977) 0.85

Proposal of a CT scoring system of the paranasal sinuses in diagnosing cystic fibrosis. Eur Radiol (2003) 0.85

SPG11--the most common type of recessive spastic paraplegia in Norway? Acta Neurol Scand Suppl (2008) 0.85

Inheritance of skewed X chromosome inactivation in a large family with an X-linked recessive deafness syndrome. Am J Med Genet (1996) 0.84

Ataxia with vitamin E deficiency in southeast Norway, case report. Acta Neurol Scand Suppl (2009) 0.83

Development and validation of a self-administered questionnaire for myasthenia gravis patients. Neuroepidemiology (2010) 0.83

Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene. Acta Neurol Scand Suppl (2014) 0.81

Cerebellar ataxia in the eastern and southern parts of Norway. Acta Neurol Scand Suppl (2007) 0.81

Proton magnetic resonance spectroscopy and cognition in patients with spastin mutations. J Neurol Sci (2008) 0.80

Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway. Exp Clin Endocrinol Diabetes (2009) 0.80

Smoking and socio-economic status may affect myasthenia gravis. Eur J Neurol (2012) 0.80

Hypoplasia of the sphenoid sinuses as a diagnostic tool in cystic fibrosis. Acta Radiol (1999) 0.78

Genetic variants affecting the neural processing of human facial expressions: evidence using a genome-wide functional imaging approach. Transl Psychiatry (2012) 0.78

SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene. Acta Neurol Scand (2011) 0.77

394delTT: a Nordic cystic fibrosis mutation. Hum Genet (1994) 0.76

[Genotyping of apolipoprotein E]. Tidsskr Nor Laegeforen (1993) 0.75